A new study reveals that dual-atom catalysts behave in a fundamentally different way than scientists previously thought, challenging a long-standing model used to predict catalytic performance.
Pharmaceutical and biopharmaceutical laboratories increasingly need to characterize complex samples that contain APIs, ...